Skip to main content

Table 2 Baseline characteristics of all patients

From: Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases

Characteristic

Results

Former or current smoking, n(%)

151 (8.9)

Always drinking, n(%)

107 (6.3)

Comorbidities, n(%)

 Diabetes Mellitus

203 (11.9)

 Hypertension

424 (24.9)

 Dyslipidemia

284 (16.7)

 Hyperuricemia

395 (23.2)

 Hypovitaminosis D

1167 (68.6)

Complications, n(%)

 Femoral head necrosis

28 (1.6)

 Osteoporotic fracture

75 (4.4)

Medication history, yes, n(%)

 Former or current chronic oral Glucocorticoid therapy

713 (41.9)

 NSAIDs

799 (47.0)

 cDMARDs

  1 Type

261 (15.5)

  2 Types

336 (20.0)

  3 Types

124 (7.4)

 bDMARDs

112 (6.6)

Blood calcium level, mean (SD)

2.6 (7.8)

Serum phosphate level, mean (SD)

1.3 (2.6)

Serum creatinine level, median [IQR]

62.0 [53.0, 75.3]

Serum Uric acid level, n(%)

 < 360

1068 (63.6)

 360–419

249 (14.8)

 420 ~ 539

243 (14.5)

 ≥540

118 (7.0)

CRP, median [IQR]

7.1 [1.5, 30.9]

ESR, median [IQR]

34.5 [15.0, 66.0]

Serum 25(OH)D3 level, mean (SD)

64.0 (26.3)

Elevated inflammatory markers, n(%)

 ESR

972 (63.8)

 CRP

729 (47.8)

  1. NSAIDs non-steroidal anti-inflammatory drugs, cDMARDs conventional disease-modifying anti-rheumatic drugs, bDMARDs biological disease-modifying anti-rheumatic drugs, ESR erythrocyte sedimentation rate, CRP c-reactive protein